Rosen Quoted on FDA Requirements for Drug Shelf Life
September 22, 2016
Modern Healthcare
Partner David Rosen was quoted in a Modern Healthcare article, “Extending EpiPen Shelf Life Could be a Relief for Patients, Costly for Mylan,” on September 22, 2016. The article discussed Mylan’s announcement to extend the shelf life of its EpiPen, currently the pricey devices must be replaced nearly every year. Rosen commented on the Food and Drug Administration regulations required to request an expiration date change, and said if the company’s data is solid, the process is pretty straightforward and objective. He continued and said the company may have changed its manufacturing process or it may be using some kind of chemical stabilizer in its epinephrine solution to prevent oxidation and lower its sensitivity to heat.
People
Related News
May 27, 2025
In the News
Foley's Silicon Valley Corporate Additions Featured in Legal Press
Foley & Lardner LLP partners Gurpreet Bal and Shaalu Mehra are highlighted in legal press for their recent arrival to the firm.
May 21, 2025
In the News
Nathaniel Lacktman Shares Insight on Virtual Second Opinion Programs
Foley & Lardner LLP partner Nathaniel Lacktman highlighted considerations for virtual second-opinion programs (VSOs) in the Physician's Weekly article, "Navigating Licensure Risks in Virtual Second-Opinion Programs."
May 16, 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.